Loading...
XNYS
DOC
Market cap11bUSD
Sep 17, Last price  
20.50USD
1D
0.74%
1Q
4.81%
Jan 2017
-31.02%
Name

Healthpeak Properties Inc

Chart & performance

D1W1MN
XNYS:DOC chart
P/E
38.21
P/S
3.97
EPS
0.54
Div yield, %
1.46%
Shrs. gr., 5y
5.56%
Rev. gr., 5y
11.40%
Revenues
2.82b
+4.52%
619,087,000982,509,0001,025,818,0001,157,030,0001,255,134,0001,724,798,0001,900,722,0002,099,878,0002,266,279,0002,544,312,0002,129,294,0001,848,378,0001,846,689,0001,997,383,0001,644,875,0001,896,184,0002,061,178,0002,181,003,0002,700,449,0002,822,512,000
Net income
294m
+20.74%
417,547,000589,015,000448,495,000130,199,000330,709,000538,891,000832,540,000970,837,000922,233,000-559,235,000627,747,000414,169,0001,061,093,00068,686,000227,106,000131,628,000500,449,000306,009,000243,142,000293,577,000
CFO
1.25b
+16.95%
334,216,000453,051,000568,697,000515,634,000580,498,000724,161,0001,034,870,0001,148,987,0001,248,621,0001,222,145,0001,214,131,000847,041,000848,709,000846,073,000758,431,000795,248,000900,261,000976,882,0001,070,497,0001,251,959,000
Dividend
Feb 13, 20240.3 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Healthpeak Properties, Inc., an S&P 500 constituent, operates as a fully integrated real estate investment trust (REIT). The company specializes in the acquisition and development of premium properties across three private-pay healthcare segments: Life Science, Medical Office, and Senior Housing. This focus is meticulously crafted to deliver stability amidst the cyclical nature of the industry. Healthpeak leverages its profound expertise in the healthcare property market, coupled with an ambitious outlook for sustained, long-term expansion.

Related entities

Subsidiaries (5)
Healthpeak OP, LLC
Dr California III Holdings, LLC
Dr California IV Holdings, LLC
Janus Living OP, LLC
Janus Living, Inc.
URL
https://www.healthpeak.com/
IPO date
May 23, 1985
Employees
199
Domiciled in
US
Incorporated in
US
Legal address
C/O The Corporation Trust Incorporated
2405 York Road
Suite 201
Lutherville Timonium, MD 21093
US
Headquarters
4600 South Syracuse Street
Suite 500
Denver, CO 80237
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT